Royal Bank of Canada’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $14K | Sell |
|
|||||
|
2025
Q2 | $32K | Sell |
|
|||||
|
2025
Q1 | $36K | Buy |
|
|||||
|
2024
Q4 | $10K | Sell |
|
|||||
|
2024
Q3 | $15K | Sell |
|
|||||
|
2024
Q2 | $24K | Buy |
|
|||||
|
2024
Q1 | $3K | Sell |
|
|||||
|
2023
Q4 | $60K | Sell |
|
|||||
|
2023
Q3 | $264K | Sell |
|
|||||
|
2023
Q2 | $849K | Buy |
|
|||||
|
2023
Q1 | $243K | Buy |
|
|||||
|
2022
Q4 | $238K | Buy |
|
|||||
|
2022
Q3 | $50K | Buy |
|
|||||
|
2022
Q2 | $54K | Sell |
|
|||||
|
2022
Q1 | $198K | Sell |
|
|||||
|
2021
Q4 | $767K | Sell |
|
|||||
|
2021
Q3 | $19.9M | Buy |
|
|||||
|
2021
Q2 | $22.6M | Sell |
|
|||||
|
2021
Q1 | $38.2M | Buy |
|
|||||
|
2020
Q4 | $23.2M | Sell |
|
|||||
|
2020
Q3 | $28M | Sell |
|
|||||
|
2020
Q2 | $29.1M | Sell |
|
|||||
|
2020
Q1 | $23.4M | Buy |
|
|||||
|
2019
Q4 | $21.5M | Sell |
|
|||||
|
2019
Q3 | $23M | Sell |
|
|||||
|
2019
Q2 | $23.2M | Sell |
|
|||||
|
2019
Q1 | $30.3M | Sell |
|
|||||
|
2018
Q4 | $38.2M | Sell |
|
|||||
|
2018
Q3 | $62.4M | Sell |
|
|||||
|
2018
Q2 | $53.5M | Sell |
|
|||||
|
2018
Q1 | $61.7M | Sell |
|
|||||
|
2017
Q4 | $58M | Buy |
|
|||||
|
2017
Q3 | $45.4M | Buy |
|
|||||
|
2017
Q2 | $32.5M | Buy |
|
|||||
|
2017
Q1 | $27.3M | Buy |
|
|||||
|
2016
Q4 | $25.1M | Buy |
|
|||||
|
2016
Q3 | $11.5M | Buy |
|
|||||
|
2016
Q2 | $442K | Sell |
|
|||||
|
2016
Q1 | $690K | Sell |
|
|||||
|
2015
Q4 | $1.19M | Buy |
|
|||||
|
2015
Q3 | $127K | Buy |
|
|||||
|
2015
Q2 | $116K | Sell |
|
|||||
|
2015
Q1 | $472K | Sell |
|
|||||
|
2014
Q4 | $449K | Sell |
|
|||||
|
2014
Q3 | $352K | Sell |
|
|||||
|
2014
Q2 | $447K | Buy |
|
|||||
|
2014
Q1 | $456K | Sell |
|
|||||
|
2013
Q4 | $1.53M | Buy |
|
|||||
|
2013
Q3 | $451K | Buy |
|
|||||
|
2013
Q2 | $303K | Buy |
|